A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia (UniSA) have …

Stanford Medicine has led a study in mice that suggests inhibiting the LRRK2 enzyme could prevent neuron death in patients with a form of Parkinson’s disease caused by a genetic mutation. The research, published in Science Signaling, indicates that …

David Krumholtz was a child actor with a bit of an attitude... until he met Michael J. Fox. Krumholtz and Fox starred together in the movie Life With Mikey, which was all about child stars. Fox - who is noted for being a nice guy offscreen as well as …

"In two to three years, Insightec could be profitable," Dr. Maurice Ferré, CEO of the veteran Israel medical device company, told "Globes" recently. Insightec profitable? Let’s take a look. This is a company that in the course of its …

July 9 (UPI) -- A common virus once thought harmless to humans might be linked to Parkinson's disease, a new study says. The germ, Human Pegivirus (HPgV), was found in half the autopsied brains of patients with Parkinson's, but not in any brains …

Breadcrumb Trail Links News Local News Can a drug used for decades in Europe to treat the common cough be repurposed to slow or stop the progression of certain kinds of dementia? St. Joseph’s Health Care on Grosvenor Street in London. Photo taken on Monday …

CHICAGO (WLS) -- Parkinson's disease is a neurological disorder that affects more than a million Americans. Groundbreaking new research released from Northwestern Medicine discovered that a usually harmless virus in the blood, may be triggering …

Korean medical researchers have developed a generative AI technology capable of diagnosing Parkinson's disease -- which is often difficult to identify --with an accuracy of up to 99.7 percent and predicting changes in patients’ brain images. Parkinson…

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company dedicated to central nervous system (CNS) disorders, and Dizlin Pharmaceuticals AB (Dizlin), a Swedish R&D company focused on late-stage Parkinson’s disease (PD), …

New Delhi: The side of the body that Parkinson's disease affects initially -- right or left -- could help predict whether a patient might experience cognitive decline or psychiatric symptoms as the condition advances, a study has suggested. Researchers …